Lupin Gains After Receiving USFDA EIR for Sambhajinagar Facility
Mumbai, 13 November (Udaipur Kiran)। Shares of Lupin edged higher on Thursday after the company announced it has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its Chhatrapati Sambhajinagar (Aurangabad) facility. The EIR follows a product-specific Pre-Approval Inspection (PAI) conducted by the USFDA between September 1–5, 2025. Lupin’s … Read more
